礼来投资4000万美元，与Absci合作开发AI设计抗体
Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201
Eli Lilly's investment in AI-designed therapeutics could revolutionize treatment options for conditions lacking effective injectable solutions. The post Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201 appeared first on Crypto Briefing.
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力